On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns ...

BTIG analysts have downgraded (NYSE:GMED) from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

Globus Medical, Inc. operates as a medical device ... It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical ...

From new partnerships and launches, here are six developments from Globus Medical so far in 2025. 1. OsteoCentric Technologies entered into a non-exclusive licensing agreement with Globus Medical.

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst ...

Is now the time to buy ICU Medical? Access our full analysis report here, it’s free. Medical Devices & Supplies - Specialty company Globus Medical (NYSE:GMED) jumped 5.8%. Is now the time to buy ...

Globus Medical, Inc. (NYSE: GMED) has announced its financial results for the first quarter of 2025, reporting revenue of ...

On Friday, Oppenheimer analysts adjusted their outlook on Globus Medical (NYSE: GMED), reducing the price target from $90.00 to $78.00, while keeping a Perform rating on the stock.This adjustment ...

Across the recent three months, 6 analysts have shared their insights on Globus Medical GMED, expressing a variety of opinions spanning from bullish to bearish. Summarizing their recent ...

May 08, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (GMED), a leading musculoskeletal ... We will continue to invest and provide innovative and clinically advanced products and solutions that ...

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2025.